Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: Claude Robitaille who wrote (880)	5/26/1999 9:58:00 PM
From: William Whitehead Jr.	Read Replies (1) \| Respond to of 2344

RE: Shareholder's Meeting Attended today's meeting in Toronto. Was impressed and quite satisfied with the job they did. Dr. McPherson fielded a number of tough questions - particularly from a U.S. investor representing 700,000 shares. A couple of points stuck with me: 1) the company has hit every objective/milestone from last year, 2) they are developing a rich vaccine pipeline. They are more than just a one or two 'horse' company, 3) company will become more aggressive in getting their story out. I'm quite satisfied - will not be selling any of my stock. May even look to pick-up another 5,000 or so (on dips) by year-end. Whitey,